SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity

Authors: Manali, Maria;

Bissett, Laura A.;

Amat, Julien A.R.;

Logan, Nicola;

Scott, Sam;

Hughes, Ellen C.;

Harvey, William T.;

Orton, Richard J.;

Thomson, Emma C. ;

Gunson, Rory N.;

Viana, Mafalda;

Willett, Brian;

Murcia, Pablo R.

Source: Journal of Infectious Diseases

Full text

: https://dx.doi.org/10.1093/infdis/jiac332

Abstract

No abstract available.

Rights

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite as

Manali, M., Bissett, L., Amat, J., Logan, N., Scott, S., Hughes, E., Harvey, W., Orton, R., Thomson, E., Gunson, R., Viana, M., Willett, B. & Murcia, P. 2022, 'SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity', Journal of Infectious Diseases, article no: jiac332. https://dx.doi.org/10.1093/infdis/jiac332

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://dx.doi.org/10.1093/infdis/jiac332

Repository URI: http://eprints.gla.ac.uk/275709/